This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies
February 27 - March 2, 2023 | Part of BPI West
San Diego Convention CenterSan Diego, CA

February 27 - March 2, 2023 | Part of BPI West
San Diego Convention Center,
San Diego, CA

CAR, T, AND EMERGING CELL LINES: IMPROVE THE SAFETY,  EFFICACY & REACH OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Revolutionizing cell and gene engineering - ground breaking autologous, allogeneic and in vivo treatments for blood borne and solid tumors

AGENDA IS NOW LIVE!

Our agenda is now posted for the Next Generation CAR & T Cell Therapies Hybrid Event. View our exciting series of talks, panels, and networking opportunities! 

NEW FOR 2023: we will be a co-located with BioProcess International US West! Mark your calendar to join us at next year's event held February 27 - March 2, 2023 as we return to the San Diego Convention Center. Get the benefit of both events by purchasing a ticket soon! 

Novel Technological Advances & Applications to help you Revolutionize Early Phase Development

Below are the key topics to be covered during this years event.

Emerging CGT 2.0 Cell Lines

The exploration of novel cell lines to be used in CAR-based therapies has opened many possibilities for future ‘CGT 2.0’ treatments, both allogeneic and autologous. 

Join us at our new CAR & T Cell Therapies track within BPI West to learn more about these emerging CGT 2.0 cell lines, and the opportunities they hold.

Overcome Solid Tumour Obstacles and Improve Efficacy

Novel developments in how to approach solid tumour treatment with CAR-T and cutting-edge cell modalities are improving treatment outcomes. 

Learn more about overcoming solid tumour obstacles by hearing from experts about their approaches to improve the efficacy of your developing therapies. 

New Horizons with In Vivo and Post CAR Approaches

From current issues to upcoming potentials, the future of the field is vast. New receptor modalities hope to solve the shortcomings of CAR, and an In Vivo approach may revolutionise CGT administration. 

Attend Next Generation CAR & T Cell Therapies 2023 to learn about the findings from experts in this ever-evolving space. 

CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2023

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)7717 508900